Aanouz, I., Belhassan, A., El Khatabi, K., Lakhlifi, T., El Idrissi, M., & Bouachrine, M. (2020). Moroccan medicinal plants as inhibitors of COVID-19: Computational investigations. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2020.1758790
Abdelli, I., Hassani, F., Brikci, & S.B., Said. (2020). In silico study the inhibition of Angiotensin converting enzyme 2 receptor of COVID-19 by Ammoidesverticillata components harvested from western Algeria. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2020.1763199
Adem, S., Eyupoglu, V., Sarfraz, I., Rasul, A., & Ali, M. (2020). Identification of potent COVID–19 main protease (Mpro) inhibitors from natural polyphenols: an in silico strategy unveils a hope against CORONA. Preprints, 2020030333. doi: 10.20944/preprints202003.0333.v1
Aldeghi, M., Bodkin, M.J., Knapp, S., & Biggin, P.C. (2017). Statistical analysis onthe performance of molecular mechanics poissonboltzmann surface area versus absolute binding free energy calculations: bromodomains as a case study. Journal of Chemical Information and Modeling, 57(9), 2203-2221.
Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J.R., & Hilgenfeld, R. (2003). Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science, 300, 1763-1767.
Anand, K., Yang, H., Bartlam, M., Rao, Z., & R. Hilgenfeld. (2005). Coronavirus main proteinase: Target for antiviral drug therapy. In A. Schmidt, O. Weber, & M. H. Wolff (Eds.), Coronaviruses with special emphasis on first insights concerning SARS (pp. 173–199). Birkhäuser Basel. 10.1007/3-7643-7339-3_9.
Benson, N.C., & Daggett, V. (2012). A comparison of multiscale methods for the analysis of molecular dynamics simulations. The Journal of Physical Chemistry B, 116(29), 8722-8731.
Berendsen, H.J.C., van der Spoel, D., & van Drunen, R. (1995). GROMACS: a message-passing parallel molecular dynamics implementation. Computer Physics Communications, 91(1-3), 43-56.
Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T.N., Weissig, H., Shindyalov, I.N., & Bourne, P.E. (2000). The protein data bank. Nucleic Acids Research, 28, 235-242. doi:10.1093/nar/28.1.235
Bhatraju, P.K., Ghassemieh, B.J., Nichols, M., Kim, R., Jerome, K.R., Nalla, A.K., Greninger, A.L., Pipavath, S., Wurfel, M.M., Evans, L., Kritek, P.A., West, T.E., Luks, A., Gerbino, A., Dale, C.R., Goldman, J.D., O'Mahony, S., & Mikacenic, C. (2020). The New England Journal of Medicine. doi: 10.1056/NEJMoa2004500
Boopathi, S., Poma, A.B., & Kolandaivel, P. (2020). Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2020.1758788
Burley, S. K., Berman, H. M., Bhikadiya, C., Bi, C., Chen, L., Di Costanzo, L., & Feng, Z. (2019). RCSB Protein Data Bank: biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy. Nucleic Acids Research, 47(D1), 464-474.
Chan, J.F.-W., Yuan, S., Kok, et al. (2020). A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. The Lancet, 395(10223), 514–523. doi:10.1016/S0140-6736(20)30154-9
Chandel, V., Raj, S., Rathi, B., & Kumar, D. (2020). In silico identification of potent COVID–19 main protease inhibitors from FDA approved antiviral compounds and active phytochemicals through molecular docking: a drug repurposing approach. Preprints, 2020030349.
Chang, C., Lo, S.-C., Wang, Y.-S., & Hou, M.-H. (2016). Recent insights into the development of therapeutics against coronavirus diseases by targeting N protein. Drug Discovery Today, 21(4), 562–572.
Chang, Y., Tung, Y., Lee, K., Chen, T., Hsiao, Y., Chang, H & Shih, S. (2020). Potential therapeutic agents for COVID–19 based on the analysis of protease and RNA polymerase docking. Priprints, 2020020242. doi: 10.20944/preprints202002.0242.v1
Chen, Y., Liu, Q., & Guo, D. (2020). Emerging coronaviruses: Genome structure, replication, and pathogenesis. Journal of Medical Virology, 92(4), 418–423.
Contini, A. (2020): Virtual screening of an FDA approved drugs database on two COVID-19 coronavirus proteins. ChemRxiv. Preprint. doi: doi.org/10.26434/chemrxiv.11847381.v1
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. (2020). The species severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology, 1. 10.1038/s41564-020-0695-z.
Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https://doi.org/10.1038/srep42717
Das, S., Sarmah, S., Lyndem, S., & Roy, A.S. (2020). An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2020.1763201
de Wit, van Doremalen, N., Falzarano, D., & Munster, V. J. (2016). SARS and MERS: Recent insights into emerging coronaviruses. Nature Reviews Microbiology, 14(8), 523–534.
Devaux, C., Rolain, J., Colson, P &Raoult, D. (2020). New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID–19?.International Journal of Antimicrobial Agents, 105938.
Elfiky A.A. (2020a). SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: An in-silico perspective. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2020.1761882
Elfiky A.A. (2020b). Natural products may interfere with SARS-CoV-2attachment to the host cell. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2020.17618
Elfiky, A.A., & Azzam, E.B. (2020). Novel guanosine derivatives against MERS CoV polymerase: An in-silico perspective, Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2020.1758789
Elmezayen, A.D., Al-Obaidi, A., Şahin, A.T., & Yelekci, K. (2020). Drug repurposing for coronavirus (COVID-19): in silicoscreening of knowndrugs against coronavirus 3CL hydrolase and protease enzymes. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2020.1758791
Enayatkhani, M., Hasaniazad, M., Faezi, S., Guklani, H., Davoodian, P., Ahmadi, N., Einakian, M.A., Karmostaji, A., & Ahmadi, K. (2020). Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in silico study. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2020.1756411
Enmozhi, S.K., Raja, K., Sebastine, I., & Joseph, J. (2020). Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in-silico approach. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2020.1760136
Gajula, M.N.P. (2008). Computer simulation meets experiment: molecular dynamics simulations of spin labeled proteins
MNV Prasad Gajula, PhD dissertation 2008/3/18; urn:nbn:de:gbv: 700-2008041631 Universität Osnabrück
Gajula, M.N.P., Kumar, A., & Ijaq, J. (2016). Protocol for molecular dynamics simulations of proteins. Bio-protocol, 6, 1-11. doi:10.21769/BioProtoc.2051
Gentile, D., Patamia, V., Scala, A., Sciortino, M. T., Piperno, A., & Rescifina, A. (2020). Inhibitors of SARS-CoV–2 main protease from a library of marine natural products: a virtual screening and molecular modeling study. Preprints, 2020030372.
Gilling, D.H., Kitajima, M., Torrey, J.R., & Bright, K.R. (2014). Antiviral efficacy and mechanisms of action of oregano essential oil and its primary component carvacrol against murine norovirus. Journal of Applied Microbiology, 116(5), 1149-1163.
Gonzalez-Paz, L.A., Lossada, C.A., Moncayo, L.S., Romero, F., Paz, J.L., Vera-Villalobos, J., Pérez, A.E., San-Blas, E., Alvarado, Y.J. (2020). Theoretical molecular docking study of the structural disruption of the viral 3CL-protease of COVID19 induced by binding of capsaicin, piperine and curcumin part 1: a comparative study with chloroquine and hydrochloroquine two antimalaric drugs. Research Square, (preprint). doi: 10.21203/rs.3.rs-21206/v1
Gorden, D.E., Gwendolyn, M.J., Bouhaddou, M., et al. (2020). A SARS-CoV-2-human protein-protein interaction map reveals drug targets and potential drug-repurposing. bioRxiv. https://doi.org/10.1101/2020.03.22.002386
Gupta, M.K., Vemula, S., Donde, R., Gouda, G., Behera, L., & Vadde, R. (2020). In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2020.1751300
Hasan, A., Paray, B.A., Hussain, A., Qadir, F.A., Attar, F., Aziz, F.M., Sharifi, M., Derakhshankhah, H., Rasti, B., Mehrabi, M., Shahpasand, K., Saboury, A.A., & Falahati, M. (2020). A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2020.1754293
Hemida, M. G., & Ba Abduallah, M. M. (2020). The SARS-CoV-2 outbreak from a one health perspective. One Health, 100127.
Hyldgaard, M., Mygind, T., & Meyer, R. L. (2012). Essential oils in food preservation: mode of action, synergies, and interactions with food matrix components. Frontiers in Microbiology, 3, 12. doi: 10.3389/fmicb.2012.00012
Islam, R., Parves, R., Paul, A.S.,Uddin, N., Rahman, M.S., Mamun, A.A., Hossain, M.N., Ali, M.A., & Halim, M.A. (2020). A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2020.1761883
Jee, B., Kumar, S., Yadav, R., Singh, Y., Kumar, A., & Sharma, M. (2018). Ursolic acid and carvacrol may be potential inhibitors of dormancy protein small heat shock protein16.3 of Mycobacterium tuberculosis, Journal of Biolomolecular Structure and Dynamics, 36(13), 3434-3443.
Jesus, J.A., G. Lago, J.H., Laurenti, M.D., Yamamoto, E.S., & D. Passero, L.F. (2015). Antimicrobial activity of oleanolic and ursolic acids: an update. Evidence-Based Complementary and Alternative Medicine, 2015, 620472. doi: https://doi.org/10.1155/2015/620472
Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., & Zhang, B. (2020). Structure of Mpro from COVID-19 virus and discovery of itsinhibitors. bioRxiv. https://www.biorxiv.org/content/10.1101/2020.02.26.964882v2
Joshi, R.S., Jagdale, S.S., Bansode, S.B., Shankar, S.S., Tellis, M.B., Pandya, V.K., Chugh, A., Giri, A.P., & Kulkarni, M.J. (2020). Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease, Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2020.1760137
Kaisari, E., & Borruat, F. (2020). Keeping an eye on hydroxychloroquine retinopathy. KlinischeMonatsblätterfürAugenheilkunde. Efirst.
Kamalabadi, M., Astani, A., & Nemati, F. (2018). Anti-viral effect and mechanism of carvacrol on herpes simplex virus type 1. International Journal of Molecular Laboratory, 5(2), 113-122.
Khaerunnisa, S., Kurniawan, H., Awaluddin, R., Suhartati, S., & Soetjipto, S. (2020). Potential inhibitor of COVID–19 main protease (Mpro) from several medicinal plant compounds by molecular docking study. Preprints, 2020030226.
Khan, S.A., Zia, K., Ashraf, S., Uddin, R., & UI-Haq, Z. (2020). Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. Journal of Biomolecular Structure and Dynamics, 1-10. doi: 10.1080/07391102.2020.1751298.
Khwaza, V., Oyedeji, O.O., & Aderibigbe, B.A. (2018). Antiviral activities of oleanolic acid and its analogues. Molecules, 23(9), 2300. doi: 10.3390/molecules23092300
Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B.A., Thiessen, P.A., Yu, B., Zaslavsky, L., Zhang, J., &Bolten, E.E. (2019). PubChem 2019 update: improved accesses to chemical data. Nucleic Acids Research, 47(D1), 1102-1109. doi: 10.1093/nar/gky1033.
Kumar, A., Kumar, R., Sharma, M., Kumar, U., Gajula, M.NV.P., & Singh, K.P. (2018). Uttarakhand medicinal plants database (UMPDB): a platform for exploring genomic, chemical, and traditional knowledge. Data (MDPI), 3(1), 7. doi: 10.3390/data3010007
Kumar, A., Kumar, S., Kumar, A., Sharma, N., Sharma, M., Singh, K.P., Rathore, M., & Gajula, M.N.V.P. (2018). Homology modeling, molecular docking and molecular dynamics based functional insights into rice urease bound to urea. Proceedings of the National Academy of Sciences, India Section B: Biological Sciences, 88, 1539–1548.
Li, Y., Zhang, J., Wang, N., Li, H., Shi, Y., Guo, G., & Zou, Q. (2020). Therapeutic drugs targeting 2019-nCoV main protease by high-throughput screening. bioRxiv. doi:10.1101/2020.01.28.922922
Lipinski, C. A., Lombardo, F., Dominy, B. W., Feeney, P. J. 2001. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advances in Drug Delivery Reviews, 46, 3-26.
Lu, I.-L., Mahindroo, N., Liang, P.-H., Peng, Y.-H., Kuo, C.-J., Tsai, K.-C., Hsieh, H.-P., Chao, Y.-S., & Wu, S.-Y. (2006). Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease. Journal of Medicinal Chemistry, 49(17), 5154–5161.
Mackenzie, J.S., & Smith, D.W. (2020). COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don’t. Microbiology Australia, MA20013.doi: 10.1071/MA20013
Marinelli, L., Fornasari, E., Eusepi, P., Ciulla, M., Genovese, S., Epifano, F., & Cacciatore, I. (2019). Carvacrol prodrugs as antimicrobial agents. European Journal of Medicinal Chemistry, 178, 515–529. doi: 10.1016/j.ejmech.2019.05.093.
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). Autodock4 and AutoDockTools4: automated docking with selective receptor flexiblity. Journal of Computational Chemistry, 16, 2785-91.
Muralidharan, N., Sakthivel, R., Velmurugan, D., & Gromiha, M.M. (2020). Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2020.1752802
Panchangam, S.S., Vahedi, M., Megha, M.J., Kumar, A., Raithatha, K., Suravajhala, P., & Reddy, P. (2016). Saffron’omics’: The challenges of integrating omic technologies. Avicenna Journal of Phytomedicine, 6, 604–620.
Pant, S., Singh, M., Ravichandiran, V., Murty, U.S.N., Srivastava, & H.K.. (2020). Peptide-like and small-molecule inhibitors against Covid-19. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2020.1757510
Pollier, J., & Goossens, A. (2012). Oleanolic acid. Phytochemistry, 77, 10-15.
Qamar, M., Alqahtani, S., Alamri, M., & Chen, L. (2020). Structural basis of SARS-CoV–2 3CLpro and anti-COVID–19 drug discovery from medicinal plants. Journal of Pharmaceutical Analysis. Doi: https://doi.org/10.1016/j.jpha.2020.03.009
Sakkiah, S., Chandrasekaran, M., Lee, .Y, Kim, S., & Lee, K.W. (2012). Molecular modeling study for conformational changes of Sirtuin 2 due to substrate and inhibitor binding. Journal of Biomolecular Structure and Dynamics, 30(3), 235-254.
Salata, C., Calistri, A., Parolin, C., & Palù, G. (2019). Coronaviruses: A paradigm of new emerging zoonotic diseases. Pathogens and Disease, 77(9), ftaa006.
Sarma, P., Sekhar, N., Prajapat, M., Avti, P., Kaur, H., Kumar, S., Singh, S., Kumar, H., Prakash, A., Dhibar, D.P., & Medhi, B. (2020). In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2020.1753580
Schüttelkopf, A.W., & van Aalten, D. M. F. (2004). PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallographica, 60, 1355–1363.
Seah, I., & Agrawal, R. (2020). Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocular Immunology and Inflammation, 1–5.
Sharma, A.D., & Kaur, I. (2020). Eucalyptol (1,8 cineole) from eucalyptus essential Oil a potential inhibitor of COVID 19 corona virus infection by molecular docking studies. Preprints, 2020030455.
Sinha, S.K., Shakya, A., Prasad, S.K., Singh, S., Gurav, N.S., Prasad, R.S., & Gurav, S.S. (2020). An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2020.1762741
Su, S., Wong, G., Shi, W., Liu, J., Lai, A. C. K., Zhou, J., Liu, W., Bi, Y., & Gao, G. F. (2016). Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends in Microbiology, 24(6), 490–502.
Sun, N., Wong, W., & Guo, J. (2020). Prediction of potential 3CLpro-targeting anti-SARS-CoV–2 compounds from Chinese medicine. Preprints, 2020030247.
Tohmé, M.J., Giménez, M.C., Peralta, A., Colombo, M.I., & Delgui, L.R. (2019). Ursolic acid: A novel antiviral compound inhibiting rotavirus infection in vitro. International Journal of Antimicrobial Agents, 54(5), 601-609.
Umesh, Kundu, D., Selvaraj, C., Singh, S.K., & Dubey, V.K. (2020). Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2020.1763202
Veber, D. F., Johnson, S. R., Cheng, H. Y., Smith, B. R., Ward, K. W., & Kopple, K. D. 2002. Molecular properties that influence the oral bioavailability of drug candidates. Journal of medicinal chemistry, 45(12), 2615-2623.
Wade, R.C., & Goodford, P.J. (1989). The role of hydrogen-bonds in drug binding. Progress in Clinical and Biological Research, 289, 433-444.
Wadood, A., Ahmed, N., Shah, L., Ahmad, A., Hassan, H., & Shams, S. (2013). In-silico drug design: An approach which revolutionarised the drug discovery process. OA Drug Design & Delivery, 1(1), 3.
Wahedi, H.M., Ahmad, S., & Abbasi, S.W. (2020). Stilbene-based natural compounds as promising drug candidates against COVID-19. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2020.1762743
Wang, B., Guo, H., Ling, L., Ji, J., Niu, J., & Gu, Y. (2020). The chronic adverse effect of chloroquine on kidney in rats through an autophagy dependent and independent pathways. Nephron, 144(1), 53–64.
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., & Xiao, G. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research, 30(3), 269–271.
Wang, C., Horby, P. W., Hayden, F. G., & Gao, G. F. (2020). A novel coronavirus outbreak of global health concern. The Lancet, 395(10223), 470–473.
Weiss, P., & Murdoch, D.R. (2020). Clinical course and mortality risk of severe COVID-19. The Lancet, 395(10229), 1014-1015.
Woo, P. C. Y., Lau, S. K. P., Chu, C-m., Chan, K-h., Tsoi, H-w., Huang, Y., Wong, B. H. L., Poon, R. W. S., Cai, J. J., Luk, W-k., Poon, L. L. M., Wong, S. S. Y., Guan, Y., Peiris, J. S. M., & Yuen, K-Y. (2005). Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. Journal of Virology, 79(2), 884–895.
World Health Organization. (2020). Naming the coronavirus disease (covid-19) and the virus that causes it.
Woźniak, Ł., Skąpska, S., & Marszałek, K. (2015). Ursolic acid- a pentacyclic triterpenoid with a wide spectrum of pharmacological activities. Molecules, 20, 20614-20641. doi: 10.3390/molecules201119721
Wu, F., Zhao, S., Yu, B., Chen, Y.M., Wang, W., Song, Z.G., Hu, Y., Tao, Z.W., Tian, J.H., Pei, Y.Y., Yuan, M.L., Zhang, Y.L., Dai, F.H., Liu, Y., Wang, Q.M., Zheng, J.J., Xu, L., Holmes, E.C., & Zhang, Y.Z. (2020). A new coronavirus associated with human respiratory disease in China. Nature, 579 (7798), 265-269.
Xu, X., Chen, P., Wang, J., Feng, J., Zhou, H., Li, X., & Hao, P. (2020). Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Science China Life Sciences, 63(3), 457–460.
Yang, H., Bartlam, M., & Rao, Z. (2006). Drug design targeting the main protease, the Achilles’ Heel of coronaviruses. Current Pharmaceutical Design, 12(35), 4573–4590. doi:10.2174/138161206779010369
Yu, W., & MacKerell AD, Jr. (2017). Computer-aided drug design methods. Methods in Molecular Biology, 1520, 85-106. doi: 10.1007/978-1-4939-6634-9_5.
Yuan, M., Yin, W., Tao, Z., Tan, W., & Hu, Y. (2020). Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China. PLoS One, 15(3), e0230548.
Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, U., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science, eabb3405.doi: 10.1126/science.abb3405.